Case report The patient, a 62 year old Chinese man, first presented to Queen Mary Hospital in 1991 with conjunctival nodules, hard palate mass, and bilateral cervical lymphadenopathy. Biopsy at that time revealed non-Hodgkin's lymphoma. Chest x ray, barium studies of the gastrointestinal tract, and a computed tomography scan of the abdomen did not reveal other sites of lymphoma involvement. Bone marrow examination was unremarkable. The clinical staging at that time was IIB. The patient was treated with nine monthly courses of cyclophosphamide (400 mg/m' orally for five days), vincristine (1.4 mg/m' intravenously) and prednisolone (100 mg/M2 orally for seven days), and achieved clinical remission.
Various collision tumours, which are defined as the concrescence of two neighbouring independent neoplasms, have been described in the gastrointestinal tract. Examples may include squamous cell carcinoma and leiomyoma of the oesophagus,' adenocarcinoma and lymphoma of the stomach,2 adenocarcinoma and carcinoid tumour of the stomach,89 adenocarcinoma and lymphoma of the small intestine,10 and adenocarcinoma and lymphoma of the rectum. " Many of these tumours were diagnosed on examination of the excised surgical specimens, with the second tumour being discovered as an incidental finding. Here, we describe a rare case of oesophageal "collision" tumour composed of squamous cell carcinoma and mantle cell lymphoma. The two components, however, were not truly synchronous primary tumours as the mantle cell lymphoma metastasised to primary squamous cell carcinoma of the oesophagus. To In 1995 the patient presented again with dysphagia and regurgitation. Solid food could still be tolerated, and there was no significant loss of weight or appetite. Physical examination was unremarkable and no superficial lymphadenopathy or organomegaly was found. Barium swallow showed an oesophageal lesion at the level of the T6 and T7 vertebrae. Upper endoscopy revealed a right nasopharyngeal lesion and a tumour growth at middle third of the oesophagus. Biopsy specimens of the right nasopharyngeal lesion and the oesophageal tumour revealed mantle cell lymphoma and mixed squamous cell carcinoma/mantle cell lymphoma, respectively. The previous biopsy specimens of conjunctival nodules and cervical lymph nodes were reviewed and showed similar features of mantle cell lymphoma. The patient was then treated with four monthly courses of intravenous cyclophosphamide (750 mg/M2), epirubicin (50 mg/m'), vincristine (1.4 mg/M2), and oral prednisolone (100 mg/M2 for five days). The oesophageal malignant lymphoma apparently regressed on follow up endoscopy, although the carcinoma component was still present. The patient then underwent three-phase oesophagectomy. Intraoperatively, the oesophageal tumour was seen infiltrating into the left main bronchus. The subcarinal lymph node was enlarged. Histo (fig 1) . The cytological features were similar to those of the previous conjunctival and cervical lymph node biopsy specimens. Immunohistochemical studies showed that these lymphoid cells were positive for CD5, CD19 and CD22, but negative for CD3 and CD23. Surface IgD and IgM, as well as K light chain restriction, were demonstrated. A diagnosis of squamous cell carcinoma of the oesophagus coexisting with mantle cell lymphoma was made.
The histological diagnosis was subsequently confirmed by examination of the oesophagectomy specimen. The excised specimen showed a moderately differentiated squamous cell carcinoma of the oesophagus with transmural infiltration. Keratin pearl formation was frequently found. Vague nodules of small malignant lymphoid cells were also present in the submucosa, muscularis propria and adventitial soft tissue, representative of residual mantle cell lymphoma (fig 2) .
Discussion
Histological diagnosis of squamous cell carcinoma and lymphoma of the oesophagus based on examination of a small endoscopic biopsy specimen may be difficult, especially if the lymphoma component is of low to intermediate grade and detailed clinical information is not available. Assessment of the lymphoid component based on cytological atypia alone is subjective and may not be conclusive. The use of immunohistochemistry and, most importantly, correlation with the clinical history is necessary if the correct histological diagnosis is to be made.
In general, B cell non-Hodgkin's lymphoma is characterised by a monotonous population of malignant lymphoid cells, in contrast to the polymorphous cell population seen in reactive lymphoid infiltrate. Germinal centres with well defined mantle zones are not seen. As for mantle cell lymphoma,"3 the tumour cells are small to medium in size and contain irregular and occasionally cleaved nuclei, fine chromatin, small nucleoli, and scanty cytoplasm. The nuclei are paler compared with those of small lymphocytic lymphoma.
The tumour may grow in diffuse and sometimes vaguely nodular patterns. Hyaline deposits may be seen around small capillaries. Thick reticulin fibres forming a coarse alveolar network surrounding large solid group of tumour cells may also be found. The monotonous cell population, absence of germinal centre, and the subtle cytological changes raise the possibility of a diagnosis of B cell nonHodgkin's lymphoma; subsequent investiga-tions including immunohistochemical analyses must be carried out before the final conclusion is drawn.
Immunohistochemically,1"'7 mantle cell lymphoma, which is probably derived from fol- 
